The mode of action of heparan and dermatan sulfates in the regulation of hepatocyte growth factor/scatter factor
about
sameAs
Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signalingFell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra.Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factorHeparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.Enhanced bacterial virulence through exploitation of host glycosaminoglycans.Quality of different chondroitin sulfate preparations in relation to their therapeutic activity.Heparan sulfate in angiogenesis: a target for therapy.Hepatocyte growth factor/scatter factor binds to small heparin-derived oligosaccharides and stimulates the proliferation of human HaCaT keratinocytes.Analysis of Glycosaminoglycans Using Mass Spectrometry.The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns.Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.Complex influence of dermatan sulphate on breast cancer cells.Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.The morphogenic properties of oligomeric endostatin are dependent on cell surface heparan sulfate.Structural determinants of heparan sulphate modulation of GDNF signalling.A ligand-induced conformational change in apolipoprotein(a) enhances covalent Lp(a) formation.Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.Multistage Tandem Mass Spectrometry of Chondroitin Sulfate and Dermatan Sulfate.The regulatory role of heparin on c-Met signaling in hepatocellular carcinoma cells.A tandem mass spectrometric approach to determination of chondroitin/dermatan sulfate oligosaccharide glycoforms.The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor.Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis.Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density.Neuritogenic activity of chondroitin/dermatan sulfate hybrid chains of embryonic pig brain and their mimicry from shark liver. Involvement of the pleiotrophin and hepatocyte growth factor signaling pathways.Physiological Signaling and Structure of the HGF Receptor MET.Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses.
P2860
Q24296700-28E978F5-EBD5-436D-8F05-D8B5FB46386BQ30568524-0E8394CC-5216-43E7-AD09-21055D395B24Q34267718-C647D942-6BC6-4905-9D4F-C98B94872BECQ34388854-1B48C093-FD9B-4580-BDA9-E44A01FB92DDQ34611457-71BA0390-3637-4076-9945-C9FBE3D9FE8DQ37611121-78398BB8-496B-479E-9186-57FABD7D6A37Q38154506-B9B2DE54-5FA9-4A31-8634-0B42431868ABQ38292865-772B7E69-68F8-46E7-A214-CA67C676FC90Q38338415-FBA57FB2-26DE-4100-B084-5C129144217AQ38357819-08D430FD-02C5-4F7A-9DF5-3928DE6292E0Q38658691-55251D5F-1E0E-4D81-A0A5-4BCA1F3AFBAEQ38986588-4C34C9CC-8913-472B-8162-4126E5EB83B3Q39431959-BFD086D8-17E0-41E1-9923-96DEC8AD9859Q40315779-A37C6C0A-4759-4714-B6A7-2C8C2A4583B0Q40601795-23936587-EFFA-45D0-8EBC-3A25E50FB12CQ40672982-2E94598C-2E6F-4F7A-8B84-84998C7F238FQ40726384-1687CFF3-F981-4FB8-9A8A-C188DFA2C6E2Q41760865-A0A0D96E-B887-4502-8A96-A4E5D1B1EE8AQ42251558-8DE56CF8-BC69-4C6A-BB6B-A2CC06673276Q43247439-F67B8698-B5B0-4FD9-A4CD-E50BAAA7F4E8Q44504094-FE879F5B-6227-4246-ADA5-F2238B3AAA61Q46213887-B1970E53-1936-4D6D-AD80-7B01EF2FAD0DQ46835307-4C9309A3-A99D-4B0B-8A30-1D828DC7A204Q48347973-92A8F930-DFCC-4952-AB01-C4E2AAB05C4DQ50985118-FF4B55CF-D524-4BF6-820E-988CCF09C003Q55331907-05F175F6-6510-4908-91C3-0BA2B7127B38
P2860
The mode of action of heparan and dermatan sulfates in the regulation of hepatocyte growth factor/scatter factor
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The mode of action of heparan ...... e growth factor/scatter factor
@ast
The mode of action of heparan ...... e growth factor/scatter factor
@en
The mode of action of heparan ...... e growth factor/scatter factor
@nl
type
label
The mode of action of heparan ...... e growth factor/scatter factor
@ast
The mode of action of heparan ...... e growth factor/scatter factor
@en
The mode of action of heparan ...... e growth factor/scatter factor
@nl
prefLabel
The mode of action of heparan ...... e growth factor/scatter factor
@ast
The mode of action of heparan ...... e growth factor/scatter factor
@en
The mode of action of heparan ...... e growth factor/scatter factor
@nl
P356
P1476
The mode of action of heparan ...... e growth factor/scatter factor
@en
P2093
John T Gallagher
Jon A Deakin
P304
P356
10.1074/JBC.M107506200
P407
P50
P577
2002-01-11T00:00:00Z